Multi-locus interactions predict risk for post-PTCA restenosis: An approach to the genetic analysis of common complex disease

被引:45
作者
Zee R.Y.L. [1 ]
Hoh J. [2 ]
Cheng S. [3 ]
Reynolds R. [3 ]
Grow M.A. [3 ]
Silbergleit A. [3 ]
Walker K. [3 ]
Steiner L. [3 ]
Zangenberg G. [3 ]
Fernandez-Ortiz A. [4 ]
Macaya C. [4 ]
Pintor E. [4 ]
Fernandez-Cruz A. [4 ]
Ott J. [2 ]
Lindpainter K. [1 ,5 ]
机构
[1] Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
[2] Laboratory of Statistical Genetics, Rockefeller University, New York, NY
[3] Department of Human Genetics, Roche Molecular Systems, Alameda, CA
[4] Hospital Universitario San Carlos, Ciudad Universitaria, Madrid
[5] F Hoffmann-La Roche Ltd., Ciudad Universitaria, Basel
关键词
Angioplasty; Restenosis; Risk factors; SNPs;
D O I
10.1038/sj.tpj.6500101
中图分类号
学科分类号
摘要
The complexity of recognizing the potential contribution of a number of possible predictors of complex disorders is increasingly challenging with the application of large-scale single nucleotide polymorphism (SNP) typing. In the search for putative genetic factors predisposing to coronary artery restenosis following balloon angioplasty, we determined genotypes for 94 SNPs representing 62 candidate genes, in a prospectively assembled cohort of 342 cases and 437 controls. Using a customized coupled-logistic regression procedure accounting for both additive and interactive effects, we identified seven SNPs in seven genes that, together, showed a statistically significant association with restenosis incidence (P <0.0001), accounting for 11.6% of overall variance observed. Among them are candidate genes for cardiovascular pathophysiology (apolipoprotein-species and NOS), inflammatory response (TNF receptor and CD14), and cell-cycle control (p53 and p53-associated protein). Our results emphasize the need to account for complex multi-gene influences and interactions when assessing the molecular pathology of multifactorial medical entities.
引用
收藏
页码:197 / 201
页数:4
相关论文
共 28 条
[1]  
McBride W., Lange R.A., Hillis L.D., Restenosis after successful coronary angioplasty. Pathophysiology and prevention, N. Engl. J. Med, 318, pp. 1734-1737, (1988)
[2]  
Mintz G.S., Popma J.J., Pichard A.D., Kent K.M., Satler L.F., Wong C., Et al., Arterial remodeling after coronary angioplasty: A serial intravascular ultrasound study, Circulation, 94, pp. 35-43, (1996)
[3]  
Van Belle E., Bauters C., Hubert E., Bodart J.C., Abolmaali K., Meurice T., Et al., Restenosis rates in diabetic patients. A comparison of coronary stenting and balloon angioplasty in native coronary vessels, Circulation, 96, pp. 1454-1460, (1997)
[4]  
Samani N.J., Martin D.S., Brack M., Cullen J., Chauhan A., Lodwick D., Et al., Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty, Lancet, 345, pp. 1013-1016, (1995)
[5]  
Hoh J., Wille A., Zee R., Cheng S., Reynolds R., Lindpaintner K., Et al., Selecting SNPs in two-stage analysis of disease association data: A model-free approach, Ann. Hum. Genet, 64, pp. 413-417, (2000)
[6]  
Chen C.C., Lu R.B., Chen Y.C., Wang M.F., Chang Y.C., Li T.K., Et al., Interaction between the functional polymorphisms of the alcohol-metabolism genes in protection against alcoholism, Am. J. Hum. Genet, 65, pp. 795-807, (1999)
[7]  
Rice J.P., Rochberg N., Neuman R.J., Saccone N.L., Liu K.Y., Zhang X., Et al., Covariates in linkage analysis, Genet. Epidemiol, 17, pp. S691-S695, (1999)
[8]  
Casterella P.J., Teirstein P.S., Prevention of coronary restenosis, Cardiol. Rev, 7, pp. 219-231, (1999)
[9]  
Libby P., Schwartz D., Brogi E., Tanaka H., Clinton S.K., A cascade model for restenosis. A special case of atherosclerosis progression, Circulation, 86, pp. III47-III52, (1992)
[10]  
Biasucci L.M., Liuzzo G., Buffon A., Maseri A., The variable role of inflammation in acute coronary syndromes and in restenosis, Semin. Interv. Cardiol, 4, pp. 105-110, (1999)